Tampa, FL, July 20, 2017 -- Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in Booth #2 at the Association of Pathology Chairs (APC) Annual Meeting at the Omni Shoreham in Washington, DC, July 24-28.
|
||||||||
“Inspirata is pleased to once again be the Diamond Sponsor at APC’s annual meeting and we’re looking forward to helping the association celebrate its Jubilee Anniversary marking 50 years that the association has been contributing to advancements in the field of pathology,” says Inspirata CEO Satish Sanan.
Inspirata is working at the forefront of technological advancements the field of pathology with the implementation of an end-to-end digital pathology workflow solution at The Ohio State University’s James Cancer Center. While at APC next week, Inspirata will host a Corporate Workshop titled “Ushering in a New Era in Pathology: Going Digital Today” on Thursday, July 27th from 3:00 – 4:30 in the Congressional Room at the Omni Shoreham Hotel. The workshop’s headline speakers include two pathology leaders from The James who will explain how this groundbreaking initiative is unlike any other and how they gained institutional buy-in to pursue for such a long-term and far-reaching project.
The workshop also will provide a behind-the-scenes look at Inspirata’s ongoing digital pathology workflow implementation at The James, including around-the-clock scanning operations for both retrospective and prospective histopathology slides; digital pathology cockpits that the institution’s pathologists will use for primary diagnosis and remote consultations; and an array of tools for decision support, image analysis and a unique predictive assay.
Beyond these pathology-specific activities, Inspirata’s engagement at The James is a major collaborative effort that also encompasses planning and implementation services; operational management and staffing; the development of additional cockpits for research, operations and a multidisciplinary tumor board; and a variety of sponsored research projects. A cumulative benefit of these activities will be the creation of a cancer information data trust or digital archive that can be used for clinical activities as well as cost-of-care analyses, health management, education, research operations, biopharma discovery and much more.
“While rooted in digital pathology, our 10-year engagement at The James encompasses a new vision—not just for pathology—but for the entire cancer center enterprise,” explains Sanan. “We look forward to laying out the blueprint so that others can follow in the footprints of the pioneers at The James.”
About APC
The Association of Pathology Chairs (APC) is a non-profit society, which serves as the voice of academic departments of Pathology in the U.S., Canada and Puerto Rico. APC exists to provide leadership and advocacy for the dynamic discipline of Pathology and to enable academic departments to meet the demands of their three missions: medical education, research and practice. The APC provides education, training, information resources and networking opportunities for chairs, residency program directors (through PRODS), medical student educators (through UMEDS), department administrators (through PDAS), and program coordinators (through GMEAS). For more information, please visit http://www.apcprods.org/.
About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact [email protected].
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c385d383-632e-415c-b891-010a220a04eb
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/000ef9ca-4011-4cb8-8592-a280b2fab076
Marjorie Bulone Inspirata, Inc. 813-570-8905 [email protected]


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 



